{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:04:15Z","timestamp":1770221055974,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11154-016-9391-y","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T22:27:05Z","timestamp":1476916025000},"page":"355-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adrenal disorders: Is there Any role for vitamin D?"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0787-7051","authenticated-orcid":false,"given":"Giacomo","family":"Tirabassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmaria","family":"Salvio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina L.","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Della Casa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Balercia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"9391_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-016-1804-x","author":"G Muscogiuri","year":"2016","unstructured":"Muscogiuri G, Altieri B, Annweiler C, Balercia G, Pal HB, Boucher BJ, et al. Vitamin D and chronic diseases: the current state of the art. Arch Toxicol. 2016. doi: 10.1007\/s00204-016-1804-x .","journal-title":"Arch Toxicol"},{"key":"9391_CR2","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-14-0158","volume":"171","author":"G Muscogiuri","year":"2014","unstructured":"Muscogiuri G, Mitri J, Mathieu C, Badenhoop K, Tamer G, Orio F, et al. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol. 2014;171:R101\u201310.","journal-title":"Eur J Endocrinol"},{"key":"9391_CR3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ejcn.2014.265","volume":"69","author":"G Muscogiuri","year":"2015","unstructured":"Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr. 2015;69:291\u20136.","journal-title":"Eur J Clin Nutr"},{"key":"9391_CR4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12020-015-0632-8","volume":"50","author":"G Sarno","year":"2015","unstructured":"Sarno G, Daniele G, Tirabassi G, Chavez AO, Ojo OO, Orio F, et al. The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. Endocrine. 2015;50:568\u201374.","journal-title":"Endocrine"},{"key":"9391_CR5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0034-1396893","volume":"47","author":"G Muscogiuri","year":"2015","unstructured":"Muscogiuri G, Altieri B, Penna-Martinez M, Badenhoop K. Focus on vitamin D and the adrenal gland. Horm Metab Res. 2015;47:239\u201346.","journal-title":"Horm Metab Res"},{"key":"9391_CR6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/bonekey.2014.5","volume":"3","author":"D Feldman","year":"2014","unstructured":"Feldman D, Malloy JP. Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets. Bonekey Rep. 2014;3:510.","journal-title":"Bonekey Rep"},{"key":"9391_CR7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","volume":"59","author":"C Aranow","year":"2011","unstructured":"Aranow C. Vitamin D, and the immune system. J Investig Med. 2011;59:881\u20136.","journal-title":"J Investig Med"},{"key":"9391_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/nu8030135","volume":"8","author":"CS Hii","year":"2016","unstructured":"Hii CS, Ferrante A. The Non-genomic actions of vitamin D. Nutrients. 2016;8:135.","journal-title":"Nutrients"},{"key":"9391_CR9","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1096\/fj.13-242040","volume":"28","author":"AT Slominski","year":"2014","unstructured":"Slominski AT, Kim T-K, Takeda Y, Janjetovic Z, Brozyna AA, Skobowiat C, et al. ROR\u03b1 and ROR \u03b3 are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J. 2014;28:2775\u201389.","journal-title":"FASEB J"},{"key":"9391_CR10","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.bbagen.2012.04.017","volume":"1820","author":"J Lundqvist","year":"2012","unstructured":"Lundqvist J, Wikvall K, Norlin M. Vitamin D-mediated regulation of CYP21A2 transcription - a novel mechanism for vitamin D action. Biochim Biophys Acta. 2012;1820:1553\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"9391_CR11","first-page":"1056","volume":"2010","author":"J Lundqvist","year":"1801","unstructured":"Lundqvist J, Norlin M, Wikvall K. 1alpha,25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells. Biochim Biophys Acta. 1801;2010:1056\u201362.","journal-title":"Biochim Biophys Acta"},{"key":"9391_CR12","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1096\/fj.12-208975","volume":"26","author":"AT Slominski","year":"2012","unstructured":"Slominski AT, Kim T-K, Shehabi HZ, Semak I, Tang EK, Nguyen MN, et al. In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 2012;26:3901\u201315.","journal-title":"FASEB J"},{"key":"9391_CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mce.2013.12.012","volume":"383","author":"AT Slominski","year":"2014","unstructured":"Slominski AT, Kim TK, Shehabi HZ, Tang EK, Benson HA, Semak I, et al. In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. Mol Cell Endocrinol. 2014;383:181\u201392.","journal-title":"Mol Cell Endocrinol"},{"key":"9391_CR14","doi-asserted-by":"crossref","first-page":"375349","DOI":"10.1155\/2015\/375349","volume":"2015","author":"C Pilon","year":"2015","unstructured":"Pilon C, Rebellato A, Urbanet R, Guzzardo V, Cappellesso R, Sasano H, et al. Methylation status of vitamin D receptor gene promoter in benign and malignant adrenal tumors. Int J Endocrinol. 2015;2015:375349.","journal-title":"Int J Endocrinol"},{"key":"9391_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0169-328X(95)00314-I","volume":"36","author":"E Puchacz","year":"1996","unstructured":"Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res. 1996;36:193\u20136.","journal-title":"Brain Res Mol Brain Res"},{"key":"9391_CR16","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1111\/j.1742-4658.2005.04819.x","volume":"272","author":"A Slominski","year":"2005","unstructured":"Slominski A, Semak I, Zjawiony J, Wortsman J, Li W, Szczesniewski A, et al. The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J. 2005;272:4080\u201390.","journal-title":"FEBS J"},{"key":"9391_CR17","first-page":"263","volume":"2011","author":"J Lundqvist","year":"1811","unstructured":"Lundqvist J, Norlin M, Wikvall K. 1\u03b1,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism. Biochim Biophys Acta. 1811;2011:263\u201370.","journal-title":"Biochim Biophys Acta"},{"key":"9391_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MED.0000000000000062","volume":"21","author":"JM Brown","year":"2014","unstructured":"Brown JM, Vaidya A. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health. Curr Opin Endocrinol Diabetes Obes. 2014;21:193\u2013201.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"9391_CR19","doi-asserted-by":"crossref","first-page":"E877","DOI":"10.1210\/jc.2013-1126","volume":"98","author":"J McNally","year":"2013","unstructured":"McNally J, Doherty DR, Lawson ML, Al-Dirbashi OY, Chakraborty P, Ramsay T, et al. The relationship between vitamin D status and adrenal insufficiency in critically ill children. J Clin Endocrinol Metab. 2013;98:E877\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"9391_CR20","first-page":"365","volume":"98","author":"M Korwutthikulrangsri","year":"2015","unstructured":"Korwutthikulrangsri M, Mahachoklertwattana P, Lertbunrian R, Chailurkit LO, Poomthavorn P. Vitamin D deficiency and adrenal function in critically ill children. J Med Assoc Thai. 2015;98:365\u201372.","journal-title":"J Med Assoc Thai"},{"key":"9391_CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1267\/ahc.14062","volume":"48","author":"MS Khalil","year":"2015","unstructured":"Khalil MS. Vitamin D3 May ameliorate the ketoconazole induced adrenal injury: histological and immunohistochemical studies on albino rats. Acta Histochem Cytochem. 2015;48:103\u201313.","journal-title":"Acta Histochem Cytochem"},{"key":"9391_CR22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/eje.0.1470635","volume":"147","author":"MA Pani","year":"2002","unstructured":"Pani MA, Seissler J, Usadel KH, Badenhoop K. Vitamin D receptor genotype is associated with Addison's disease. Eur J Endocrinol. 2002;147:635\u201340.","journal-title":"Eur J Endocrinol"},{"key":"9391_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/eje.0.1510193","volume":"151","author":"ER Lopez","year":"2004","unstructured":"Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves\u2019 disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol. 2004;151:193\u20137.","journal-title":"Eur J Endocrinol"},{"key":"9391_CR24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0029-1241206","volume":"118","author":"M Fichna","year":"2010","unstructured":"Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Gryczy\u00f1ska M, Fichna P, Sowi\u00f1ski J, et al. Association of the CYP27B1 C(\u22121260)a polymorphism with autoimmune Addison's disease. Exp Clin Endocrinol Diabetes. 2010;118:544\u20139.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"9391_CR25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40618-014-0233-z","volume":"38","author":"G Bellastella","year":"2015","unstructured":"Bellastella G, Maiorino MI, Petrizzo M, De Bellis A, Capuano A, Esposito K, et al. Vitamin D and autoimmunity: what happens in autoimmune polyendocrine syndromes? J Endocrinol Investig. 2015;38:629\u201333.","journal-title":"J. Endocrinol. Investig"},{"key":"9391_CR26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1741-7015-11-171","volume":"11","author":"SV Ramagopalan","year":"2013","unstructured":"Ramagopalan SV, Goldacre R, Disanto G, Giovannoni G, Goldacre MJ. Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies. BMC Med. 2013;11:171.","journal-title":"BMC Med"},{"key":"9391_CR27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2265.2003.01860.x","volume":"59","author":"AM Suliman","year":"2003","unstructured":"Suliman AM, Freaney R, Smith TP, McBrinn Y, Murray B, McKenna TJ. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency. Clin Endocrinol (Oxf). 2003;59:380\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9391_CR28","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1210\/jc.2011-2757","volume":"97","author":"ZE Davidson","year":"2012","unstructured":"Davidson ZE, Walker KZ, Truby H. Clinical review: Do glucocorticosteroids alter vitamin D status? a systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab. 2012;97:738\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"9391_CR29","first-page":"399","volume":"90","author":"TJ Hahn","year":"1977","unstructured":"Hahn TJ, Halstead LR, Haddad Jr JG. Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy. J Lab Clin Med. 1977;90:399\u2013404.","journal-title":"J Lab Clin Med"},{"key":"9391_CR30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1172\/JCI109506","volume":"64","author":"TJ Hahn","year":"1979","unstructured":"Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest. 1979;64:655\u201365.","journal-title":"J Clin Invest"},{"key":"9391_CR31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2265.1980.tb02706.x","volume":"12","author":"DM Slovik","year":"1980","unstructured":"Slovik DM, Neer RM, Ohman JL, Lowell FC, Clark MB, Segre GV, et al. Parathyroid hormone and 25-hydroxyvitamin D levels in glucocorticoid-treated patients. Clin Endocrinol (Oxf). 1980;12:243\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9391_CR32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI108762","volume":"60","author":"RG Klein","year":"1977","unstructured":"Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest. 1977;60:253\u20139.","journal-title":"J Clin Invest"},{"key":"9391_CR33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1172\/JCI109902","volume":"66","author":"E Seeman","year":"1980","unstructured":"Seeman E, Kumar R, Hunder GG, Scott M, Heath 3rd H, Riggs BL. Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Invest. 1980;66:664\u20139.","journal-title":"J Clin Invest"},{"key":"9391_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1507\/endocrj1954.33.345","volume":"33","author":"N Kugai","year":"1986","unstructured":"Kugai N, Koide Y, Yamashita K, Shimauchi T, Nagata N, Takatani O. Impaired mineral metabolism in Cushing's syndrome: parathyroid function, vitamin D metabolites and osteopenia. Endocrinol Jpn. 1986;33:345\u201352.","journal-title":"Endocrinol Jpn"},{"key":"9391_CR35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/jcem-39-6-981","volume":"39","author":"JF Aloia","year":"1974","unstructured":"Aloia JF, Roginsky M, Ellis K, Shukla K, Cohn S. Skeletal metabolism and body composition in Cushing's syndrome. J Clin Endocrinol Metab. 1974;39:981\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"9391_CR36","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/jcem-54-5-1039","volume":"54","author":"JW Findling","year":"1982","unstructured":"Findling JW, Adams ND, Lemann Jr J, Gray RW, Thomas CJ, Tyrrell JB. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab. 1982;54:1039\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"9391_CR37","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","volume":"85","author":"JM Lappe","year":"2007","unstructured":"Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586\u201391.","journal-title":"Am J Clin Nutr"},{"key":"9391_CR38","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3945\/ajcn.111.015032","volume":"94","author":"MJ Bolland","year":"2011","unstructured":"Bolland MJ, Grey A, Gamble GD, Reid IR. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's health initiative (WHI) limited-access data set. Am J Clin Nutr. 2011;94:1144\u20139.","journal-title":"Am J Clin Nutr"},{"key":"9391_CR39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jsbmb.2013.11.008","volume":"140","author":"C Pilon","year":"2014","unstructured":"Pilon C, Urbanet R, Williams TA, Maekawa T, Vettore S, Sirianni R, et al. 1\u03b1,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer. J Steroid Biochem Mol Biol. 2014;140:26\u201333.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9391_CR40","first-page":"888","volume":"86","author":"D Zehnder","year":"2011","unstructured":"Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase. J Clin Endocrinol Metab. 2011;86:888\u201394.","journal-title":"J Clin Endocrinol Metab"},{"key":"9391_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/taap.1996.0204","volume":"140","author":"AS Tischler","year":"1996","unstructured":"Tischler AS, Powers JF, Downing JC, Riseberg JC, Shahsavari M, Ziar J, et al. Vitamin D3, lactose, and xylitol stimulate chromaffin cell proliferation in the rat adrenal medulla. Toxicol Appl Pharmacol. 1996;140:115\u201323.","journal-title":"Toxicol Appl Pharmacol"},{"key":"9391_CR42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/toxsci\/51.1.9","volume":"51","author":"AS Tischler","year":"1999","unstructured":"Tischler AS, Powers JF, Pignatello M, Tsokas P, Downing JC, McClain RM. Vitamin D3-induced proliferative lesions in the rat adrenal medulla. Toxicol Sci. 1999;51:9\u201318.","journal-title":"Toxicol Sci"},{"key":"9391_CR43","volume":"8","author":"C Bi","year":"2013","unstructured":"Bi C, Li B, Du L, Wang L, Zhang Y, Cheng Z, et al. Vitamin D receptor, an important transcription factor associated with aldosterone-producing adenoma. PLoS One. 2013;8, e82309.","journal-title":"PLoS One"},{"key":"9391_CR44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/jch.12825","volume":"18","author":"MR Gr\u00fcbler","year":"2016","unstructured":"Gr\u00fcbler MR, Gaksch M, Kienreich K, Verheyen N, Schmid J\u00d3 Hartaigh BW, Richtig G, et al. Effects of vitamin D supplementation on plasma aldosterone and renin-a randomized placebo-controlled trial. J Clin Hypertens (Greenwich). 2016;18:608\u201313.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"9391_CR45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cardfail.2014.01.019","volume":"20","author":"RS Boxer","year":"2014","unstructured":"Boxer RS, Hoit BD, Schmotzer BJ, Stefano GT, Gomes A, Negrea L. The effect of vitamin d on aldosterone and health status in patients with heart failure. J Card Fail. 2014;20:334\u201342.","journal-title":"J Card Fail"},{"key":"9391_CR46","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","volume":"97","author":"S Pilz","year":"2012","unstructured":"Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, et al. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. J Clin Endocrinol Metab. 2012;97:E75\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"9391_CR47","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","volume":"30","author":"C Maniero","year":"2012","unstructured":"Maniero C, Fassina A, Seccia TM, Toniato A, Iacobone M, Plebani M, et al. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. J Hypertens. 2012;30:390\u20135.","journal-title":"J Hypertens"},{"key":"9391_CR48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ajh\/hpv146","volume":"29","author":"LX Zhang","year":"2016","unstructured":"Zhang LX, Gu WJ, Li YJ, Wang Y, Wang WB, Wang AP, et al. PTH is a promising auxiliary index for the clinical diagnosis of aldosterone-producing adenoma. Am J Hypertens. 2016;29:575\u201381.","journal-title":"Am J Hypertens"},{"key":"9391_CR49","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","volume":"27","author":"AS Salcuni","year":"2012","unstructured":"Salcuni AS, Palmieri S, Carnevale V, Morelli V, Battista C, Guarnieri V, et al. Bone involvement in aldosteronism. J Bone Miner Res. 2012;27:2217\u201322.","journal-title":"J Bone Miner Res"},{"key":"9391_CR50","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","volume":"24","author":"L Ceccoli","year":"2013","unstructured":"Ceccoli L, Ronconi V, Giovannini L, Marcheggiani M, Turchi F, Boscaro M, et al. Bone health and aldosterone excess. Osteoporos Int. 2013;24:2801\u20137.","journal-title":"Osteoporos Int"},{"key":"9391_CR51","doi-asserted-by":"crossref","first-page":"836529","DOI":"10.1155\/2014\/836529","volume":"2014","author":"L Petramala","year":"2014","unstructured":"Petramala L, Zinnamosca L, Settevendemmie A, Marinelli C, Nardi M, Concistr\u00e8 A, et al. Bone and mineral metabolism in patients with primary aldosteronism. Int J Endocrinol. 2014;2014:836529.","journal-title":"Int J Endocrinol"},{"key":"9391_CR52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2008.01977.x","volume":"38","author":"Y Talmor","year":"2008","unstructured":"Talmor Y, Bernheim J, Klein O, Green J, Rashid G. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur J Clin Investig. 2008;38:548\u201354.","journal-title":"Eur. J. Clin. Investig"},{"key":"9391_CR53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/ajh\/2.7.553","volume":"2","author":"RD Bukoski","year":"1989","unstructured":"Bukoski RD, DeWan P, McCarron DA. 1,25 (OH)2 vitamin D3 modifies growth and contractile function of vascular smooth muscle of spontaneously hypertensive rats. Am J Hypertens. 1989;2:553\u20136.","journal-title":"Am J Hypertens"},{"key":"9391_CR54","doi-asserted-by":"crossref","first-page":"F1109","DOI":"10.1152\/ajprenal.00010.2013","volume":"305","author":"DK Atchison","year":"2013","unstructured":"Atchison DK, Harding P, Beierwaltes WH. Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and \u03b2-adrenergic activity. Am J Physiol Renal Physiol. 2013;305:F1109\u201317.","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"9391_CR55","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/ajh\/6.12.983","volume":"6","author":"J Shan","year":"1993","unstructured":"Shan J, Resnick LM, Lewanczuk RZ, Karpinski E, Li B, Pang PK. 1,25-dihydroxyvitamin D as a cardiovascular hormone. Effects on calcium current and cytosolic free calcium in vascular smooth muscle cells. Am J Hypertens. 1993;6:983\u20138.","journal-title":"Am J Hypertens"},{"key":"9391_CR56","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/jc.2008-1212","volume":"94","author":"O Tarcin","year":"2009","unstructured":"Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009;94:4023\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"9391_CR57","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-8587(14)70113-5","volume":"2","author":"KS Vimaleswaran","year":"2014","unstructured":"Vimaleswaran KS, Cavadino A, Berry DJ, et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabe Endocrinol. 2014;2:719\u201329.","journal-title":"Lancet Diabe Endocrinol"},{"key":"9391_CR58","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cca.2010.05.037","volume":"411","author":"A Tomaschitz","year":"2010","unstructured":"Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen risk and cardiovascular health (LURIC) study. Clin Chim Acta. 2010;411:1354\u201360.","journal-title":"Clin Chim Acta"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-016-9391-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T16:33:56Z","timestamp":1568478836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-016-9391-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["9391"],"URL":"https:\/\/doi.org\/10.1007\/s11154-016-9391-y","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}